OBN CEO Interview: Meet the Finalists, OBN Awards 2020 - Best Established Medtech Company
Event Start Date: 25/05/2021 12:00
Event End Date: 25/05/2021 13:00
Sign Up To This Event
There are currently 6 spaces left.
We are delighted to announce details of the next in our series of OBN Digital CEO Interviews with three of the innovative and exciting companies that have been shortlisted for the OBN Awards. For the next in our interview series, John Harris will be meeting the finalists of the ‘Best Established Medtech' category. Join us to hear about the exciting work that made them stand out to our judges, learn a little about each company’s story, their R&D Innovation and why they are making such an impact on the industry today.
The OBN Awards, are the most highly regarded awards event in the industry and aim to recognise and celebrate the most innovative life sciences companies across all therapy areas and functions.
Join us on Tuesday 25 May from 12:00 to 13:00 to learn more about our finalists:
Brainomix - Using AI and deep learning algorithms to develop a complete stroke imaging decision support solution to hospitals worldwide
Inivata – leader in liquid biopsy, their InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients
Oxford Nanopore Technologies - Developing a novel generation of DNA/RNA sequencing technology to enable the analysis of any living thing, by anyone, anywhere
John Harris, CEO, OBN
Michalis Papadakis, CEO, Brainomix
Clive Morris, CEO, Inivata
Tim Cowper, CFO, Oxford Nanopore Technologies